Osteoclastic Bone Resorption and the Hypercalcemia of Cancer
- 14 November 1974
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 291 (20) , 1081-1082
- https://doi.org/10.1056/nejm197411142912009
Abstract
Hypercalcemia, osteolytic lesions, and bone pain occur frequently in patients with a wide variety of neoplastic diseases. Within the last few years it has become increasingly apparent that hypercalcemia in cancer may occur without direct bone metastasis but indirectly through humoral mediators that appear to stimulate osteoclastic bone resorption. The humoral mediator in some patients has been ectopic parathyroid hormone (PTH) or parathyroid-like substances produced by tumor tissues. Initial attempts to differentiate true ectopic PTH production from nonparathyroid substances have been hampered by the complexity of the measurement of immunoreactive PTH (iPTH) in the peripheral circulation. A review of the . . .Keywords
This publication has 8 references indexed in Scilit:
- Indomethacin-Responsive Hypercalcemia in a Patient with Renal-Cell AdenocarcinomaNew England Journal of Medicine, 1974
- Immunoreactive Forms of Circulating Parathyroid Hormone in Primary and Ectopic HyperparathyroidismJournal of Clinical Investigation, 1974
- Partial Purification of Osteoclast-Activating Factor from Phytohemagglutinin-Stimulated Human LeukocytesJournal of Clinical Investigation, 1974
- Parathyroid hormone: Coming of age in clinical medicineThe American Journal of Medicine, 1973
- Nonparathyroid Humoral Hypercalcemia in Patients with Neoplastic DiseasesNew England Journal of Medicine, 1973
- Bone Resorbing Activity in Supernatant Fluid from Cultured Human Peripheral Blood LeukocytesScience, 1972
- 1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue CultureScience, 1972
- Osteolytic Sterol in Human Breast CancerScience, 1966